144 related articles for article (PubMed ID: 37858775)
1. Synergism in actions of HBV with aflatoxin in cancer development.
Jin J; Kouznetsova VL; Kesari S; Tsigelny IF
Toxicology; 2023 Nov; 499():153652. PubMed ID: 37858775
[TBL] [Abstract][Full Text] [Related]
2. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.
Kew MC
Liver Int; 2003 Dec; 23(6):405-9. PubMed ID: 14986813
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
Qi LN; Li LQ; Chen YY; Chen ZH; Bai T; Xiang BD; Qin X; Xiao KY; Peng MH; Liu ZM; Liu TW; Qin X; Li S; Han ZG; Mo ZN; Santella RM; Winkler CA; O'Brien SJ; Peng T
PLoS One; 2013; 8(12):e83465. PubMed ID: 24391771
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
7. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
8. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
McCullough AK; Lloyd RS
DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
[TBL] [Abstract][Full Text] [Related]
10. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
11. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions and metabolism of aflatoxin: an update.
McLean M; Dutton MF
Pharmacol Ther; 1995 Feb; 65(2):163-92. PubMed ID: 7540767
[TBL] [Abstract][Full Text] [Related]
13. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
[TBL] [Abstract][Full Text] [Related]
14. Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Rajagopalan MS; Busch MP; Blum HE; Vyas GN
Life Sci; 1986 Oct; 39(14):1287-90. PubMed ID: 3020328
[TBL] [Abstract][Full Text] [Related]
15. [Aflatoxins: current concepts on mechanisms of toxicity and their involvement in the etiology of hepatocellular carcinoma].
de Oliveira CA; Germano PM
Rev Saude Publica; 1997 Aug; 31(4):417-24. PubMed ID: 9595771
[TBL] [Abstract][Full Text] [Related]
16. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.
Yan RQ; Su JJ; Huang DR; Gan YC; Yang C; Huang GH
J Cancer Res Clin Oncol; 1996; 122(5):289-95. PubMed ID: 8609152
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods.
Rushing BR; Selim MI
Food Chem Toxicol; 2019 Feb; 124():81-100. PubMed ID: 30468841
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]